SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-049559
Filing Date
2018-09-14
Accepted
2018-09-14 17:26:12
Documents
5
Period of Report
2018-09-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv502912_8k.htm 8-K 21153
2 EXHIBIT 4.1 tv502912_ex4-1.htm EX-4.1 67282
3 EXHIBIT 10.1 tv502912_ex10-1.htm EX-10.1 256823
4 EXHIBIT 99.1 tv502912_ex99-1.htm EX-99.1 14344
5 GRAPHIC tv502912_ex99-1img01.jpg GRAPHIC 16247
  Complete submission text file 0001144204-18-049559.txt   383444
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20713 | Film No.: 181071930
SIC: 2836 Biological Products, (No Diagnostic Substances)